D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 86 Citations 31,473 292 World Ranking 9076 National Ranking 4831

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Enzyme
  • Gene

His primary scientific interests are in Immunology, Sepsis, Intensive care, Internal medicine and Organ dysfunction. As a part of the same scientific study, he usually deals with the Immunology, concentrating on Tight junction and frequently concerns with Ratón, Pathogenesis, Barrier function and Pathology. His research on Sepsis frequently connects to adjacent areas such as Pharmacology.

His Intensive care research integrates issues from Anesthesia, Cohort study, Anemia and Intensive care unit. Mitchell P. Fink focuses mostly in the field of Internal medicine, narrowing it down to matters related to Endocrinology and, in some cases, Resuscitation and Shock. His research investigates the link between Organ dysfunction and topics such as Clinical trial that cross with problems in Intensive care medicine and Septic shock.

His most cited work include:

  • 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference (4359 citations)
  • 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference (1505 citations)
  • The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States. (1052 citations)

What are the main themes of his work throughout his whole career to date?

Sepsis, Pharmacology, Immunology, Internal medicine and Biochemistry are his primary areas of study. His Sepsis research incorporates elements of Clinical trial and Intensive care medicine. His study in Intensive care medicine focuses on Intensive care in particular.

His research in Pharmacology focuses on subjects like Ischemia, which are connected to Pathology. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Endocrinology. His Biochemistry research includes themes of Molecular biology, Nitric oxide, Cytokine and Cell biology.

He most often published in these fields:

  • Sepsis (21.36%)
  • Pharmacology (21.04%)
  • Immunology (20.39%)

What were the highlights of his more recent work (between 2007-2018)?

  • Pharmacology (21.04%)
  • Sepsis (21.36%)
  • Inflammation (11.97%)

In recent papers he was focusing on the following fields of study:

Mitchell P. Fink focuses on Pharmacology, Sepsis, Inflammation, Immunology and Internal medicine. His work carried out in the field of Pharmacology brings together such families of science as Malondialdehyde, Critical illness, Peroxisome proliferator, Activator and Acute pancreatitis. Organ dysfunction is the focus of his Sepsis research.

His work deals with themes such as Copolymer, Polystyrene, Polymer, Nitric oxide synthase and Sorbent, which intersect with Inflammation. His study in the fields of Proinflammatory cytokine and Inflammatory response under the domain of Immunology overlaps with other disciplines such as Lepromatous leprosy. His biological study deals with issues like Endocrinology, which deal with fields such as Intestinal mucosa.

Between 2007 and 2018, his most popular works were:

  • Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity (69 citations)
  • Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance (59 citations)
  • A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass. (56 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Enzyme
  • Gene

The scientist’s investigation covers issues in Pharmacology, Molecular biology, Sepsis, Biochemistry and Lipopolysaccharide. His Pharmacology research integrates issues from Malondialdehyde, Nitric oxide synthase, Inflammation, NF-κB and Acute pancreatitis. As a member of one scientific family, Mitchell P. Fink mostly works in the field of Inflammation, focusing on Adenosine and, on occasion, Proinflammatory cytokine.

His Molecular biology research incorporates elements of Extracellular, IκBα, Receptor, HMGB1 and RAGE. His biological study spans a wide range of topics, including Cardiac surgery, Cardiopulmonary bypass and Ischemia. His research on Endocrinology and Internal medicine is centered around Lipopolysaccharide.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

Mitchell M. Levy;Mitchell P. Fink;John C. Marshall;Edward Abraham.
Intensive Care Medicine (2003)

5376 Citations

The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

Howard L. Corwin;Andrew Gettinger;Ronald G. Pearl;Mitchell P. Fink.
Critical Care Medicine (2004)

1704 Citations

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

Fisher Cj;Dhainaut Jf;Opal Sm;Pribble Jp.
JAMA (1994)

1513 Citations

Reversing established sepsis with antagonists of endogenous high-mobility group box 1

Huan Yang;Mahendar Ochani;Jianhua Li;Xiaoling Qiang.
Proceedings of the National Academy of Sciences of the United States of America (2004)

1365 Citations

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

Allan Tsung;Rohit Sahai;Hiroyuki Tanaka;Atsunori Nakao.
Journal of Experimental Medicine (2005)

1346 Citations

Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study.

John A. Kellum;Lan Kong;Mitchell P. Fink;Lisa A. Weissfeld.
JAMA Internal Medicine (2007)

856 Citations

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

Luis Ulloa;Mahendar Ochani;Huan Yang;Mahira Tanovic.
Proceedings of the National Academy of Sciences of the United States of America (2002)

768 Citations

Laboratory models of sepsis and septic shock

Mitchell P. Fink;Stephen O. Heard.
Journal of Surgical Research (1990)

755 Citations

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

Mitchell P. Fink;David R. Snydman;Michael S. Niederman;Kenneth V. Leeper Jr..
Antimicrobial Agents and Chemotherapy (1994)

636 Citations

Efficacy of Recombinant Human Erythropoietin in Critically Ill Patients: A Randomized Controlled Trial

Howard L. Corwin;Andrew Gettinger;Ronald G. Pearl;Mitchell P. Fink.
JAMA (2002)

617 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mitchell P. Fink

Jean Louis Vincent

Jean Louis Vincent

Université Libre de Bruxelles

Publications: 196

Timothy R. Billiar

Timothy R. Billiar

University of Pittsburgh

Publications: 142

Kevin J. Tracey

Kevin J. Tracey

Feinstein Institute for Medical Research

Publications: 131

Haichao Wang

Haichao Wang

Feinstein Institute for Medical Research

Publications: 112

Yoram Vodovotz

Yoram Vodovotz

University of Pittsburgh

Publications: 103

Rinaldo Bellomo

Rinaldo Bellomo

University of Melbourne

Publications: 101

Derek C. Angus

Derek C. Angus

University of Pittsburgh

Publications: 101

John A. Kellum

John A. Kellum

University of Pittsburgh

Publications: 88

Evangelos J. Giamarellos-Bourboulis

Evangelos J. Giamarellos-Bourboulis

National and Kapodistrian University of Athens

Publications: 70

Huan Yang

Huan Yang

Feinstein Institute for Medical Research

Publications: 67

Tom van der Poll

Tom van der Poll

University of Amsterdam

Publications: 67

Peter Wipf

Peter Wipf

University of Pittsburgh

Publications: 61

Mervyn Singer

Mervyn Singer

University College London

Publications: 60

Jong-Sup Bae

Jong-Sup Bae

Kyungpook National University

Publications: 59

Ping Wang

Ping Wang

Feinstein Institute for Medical Research

Publications: 59

Daniel De Backer

Daniel De Backer

Université Libre de Bruxelles

Publications: 56

Trending Scientists

Joseph Fjelstad

Joseph Fjelstad

Verdant Electronics

Yongchun Fang

Yongchun Fang

Nankai University

Maurizio Botta

Maurizio Botta

University of Siena

William Davison

William Davison

Lancaster University

Joseph D. Robson

Joseph D. Robson

University of Manchester

Gary W. Litman

Gary W. Litman

University of South Florida

Brendan G. McKie

Brendan G. McKie

Swedish University of Agricultural Sciences

Klaas Frankena

Klaas Frankena

Wageningen University & Research

Stephen T. Sherry

Stephen T. Sherry

National Institutes of Health

Jean-Paul Liégeois

Jean-Paul Liégeois

Royal Museum for Central Africa

Robert B. Zipursky

Robert B. Zipursky

McMaster University

Anna Köttgen

Anna Köttgen

University of Freiburg

Jason D. Morrow

Jason D. Morrow

Vanderbilt University

David Kirn

David Kirn

University of California, Berkeley

Loretta J. Stalans

Loretta J. Stalans

Loyola University Chicago

Something went wrong. Please try again later.